LIFEVANTAGE CORP Increase (Decrease) in Customer Deposits
LIFEVANTAGE CORP (LFVN) reported Increase (Decrease) in Customer Deposits of -$13.00 thousand for the 12-month period ending 2013-06-30, per its 10-K filed 2013-09-12.
Discontinued › Notes › ASU 2014-09 Transition
us-gaap:IncreaseDecreaseInCustomerDeposits · last filed 2013-09-12
- LIFEVANTAGE CORP increase (decrease) in customer deposits for the quarter ending 2013-06-30 was -$87.00K, a 172.50% decline year-over-year.
- LIFEVANTAGE CORP increase (decrease) in customer deposits for the quarter ending 2013-03-31 was -$347.00K.
- LIFEVANTAGE CORP increase (decrease) in customer deposits for the quarter ending 2012-12-31 was $389.00K.
- LIFEVANTAGE CORP increase (decrease) in customer deposits for the quarter ending 2012-09-30 was $32.00K, a 1500.00% increase year-over-year.
- LIFEVANTAGE CORP increase (decrease) in customer deposits for fiscal 2013 was -$13.00K, a 110.83% decline from fiscal 2012.
- LIFEVANTAGE CORP increase (decrease) in customer deposits for fiscal 2012 was $120.00K.
- LIFEVANTAGE CORP increase (decrease) in customer deposits for fiscal 2011 was -$1.00K.
| Period end | Increase (Decrease) in Customer Deposits 3 month | Increase (Decrease) in Customer Deposits 3 month as first filed | Increase (Decrease) in Customer Deposits 6 month | Increase (Decrease) in Customer Deposits 9 month | Increase (Decrease) in Customer Deposits 12 month | Increase (Decrease) in Customer Deposits 12 month as first filed |
|---|---|---|---|---|---|---|
| 2013-06-30 | -$87.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-09-12 | -$434.00K derived: sum of 2 quarters · filed 2013-09-12 | -$45.00K derived: sum of 3 quarters · filed 2013-09-12 | -$13.00K 10-K · filed 2013-09-12 | ||
| 2013-03-31 | -$347.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-05-09 | $42.00K derived: sum of 2 quarters · filed 2013-05-09 | $74.00K 10-Q · filed 2013-05-09 | $194.00K derived: sum of 4 quarters · filed 2013-09-12 | ||
| 2012-12-31 | $389.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-02-07 | $421.00K 10-Q · filed 2013-02-07 | $541.00K derived: sum of 3 quarters · filed 2013-09-12 | |||
| 2012-09-30 | $32.00K 10-Q · filed 2012-11-08 | $152.00K derived: sum of 2 quarters · filed 2013-09-12 | ||||
| 2012-06-30 | $120.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-09-12 | $120.00K 10-K · filed 2013-09-12 | $119.66K 10-K · filed 2012-09-10 | |||
| 2012-03-31 | $0.00 10-Q · filed 2013-05-09 | |||||
| 2011-09-30 | $2.00K 10-Q · filed 2012-11-08 | $922.00 10-Q · filed 2011-11-14 | ||||
| 2011-06-30 | -$1.00K 10-K · filed 2013-09-12 | -$904.00 10-K · filed 2012-09-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |